Cargando…

Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma

Detalles Bibliográficos
Autores principales:	Thirusangu, Prabhu, Ray, Upasana, Sarkar Bhattacharya, Sayantani, Oien, Derek B., Jin, Ling, Staub, Julie, Kannan, Nagarajan, Molina, Julian R., Shridhar, Viji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810529/ https://www.ncbi.nlm.nih.gov/pubmed/36443398 http://dx.doi.org/10.1038/s41388-022-02470-z

Ejemplares similares

PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
por: Thirusangu, Prabhu, et al.
Publicado: (2022)

Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer
por: Xiao, Yinan, et al.
Publicado: (2021)

PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses
por: Sarkar Bhattacharya, Sayantani, et al.
Publicado: (2019)

Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines
por: Oien, Derek B., et al.
Publicado: (2021)

Exploiting LRRC15 as a Novel Therapeutic Target in Cancer
por: Ray, Upasana, et al.
Publicado: (2022)

Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations
por: Oien, Derek B., et al.
Publicado: (2021)

Quinacrine-Induced Autophagy in Ovarian Cancer Triggers Cathepsin-L Mediated Lysosomal/Mitochondrial Membrane Permeabilization and Cell Death
por: Thirusangu, Prabhu, et al.
Publicado: (2021)

Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer
por: Ray, Upasana, et al.
Publicado: (2022)

Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
por: Mondal, Susmita, et al.
Publicado: (2018)

Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization
por: Ray, Upasana, et al.
Publicado: (2021)

PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
por: Ray, Upasana, et al.
Publicado: (2023)

Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer
por: Kumar, Sanjeev, et al.
Publicado: (2019)

Correction: Actin Cytoskeleton Regulates Hippo Signaling
por: Reddy, Pradeep, et al.
Publicado: (2013)

Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
por: Feng, Chenchen, et al.
Publicado: (2021)

Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017)

Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022)

DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model
por: Aalam, Syed Mohammed Musheer, et al.
Publicado: (2022)

Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
por: Rahmat, Muhammad Bakhait, et al.
Publicado: (2019)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
por: Li, Ximing, et al.
Publicado: (2020)

Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
por: Kotowski, Krzysztof, et al.
Publicado: (2021)

Correction to: ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma
por: Chen, Qian, et al.
Publicado: (2021)

Role of PFKFB3-driven glycolysis in sepsis
por: Xiao, Min, et al.
Publicado: (2023)

The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
por: Trojan, Sonia E., et al.
Publicado: (2019)

Correction: Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway
Publicado: (2020)

Publisher Correction: IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function
por: Montemurro, Chiara, et al.
Publicado: (2019)

Publisher Correction: Inhibition of eNOS by L-NAME resulting in rat hind limb developmental defects through PFKFB3 mediated angiogenetic pathway
por: Wu, Ziqiang, et al.
Publicado: (2021)

Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014)

Correction: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
por: Mitamura, Takashi, et al.
Publicado: (2014)

Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2023)

A Potential Oncogenic Role for PFKFB3 Overexpression in Gastric Cancer Progression
por: Lei, Lan, et al.
Publicado: (2021)

PFKFB3: A Potential Key to Ocular Angiogenesis
por: Zhou, Zi-Yi, et al.
Publicado: (2021)

Functional diversity of PFKFB3 splice variants in glioblastomas
por: Heydasch, Ulli, et al.
Publicado: (2021)

Correction: Salvador–Warts–Hippo pathway regulates sensory organ development via caspase-dependent nonapoptotic signaling
por: Wang, Lan-Hsin, et al.
Publicado: (2019)

Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway
por: Wang, Xuehui, et al.
Publicado: (2021)

Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
por: Jung, Deok-Beom, et al.
Publicado: (2019)

Metformin is synthetically lethal with glucose withdrawal in cancer cells
por: Khurana, Ashwani, et al.
Publicado: (2012)

PFKFB3 promotes proliferation, migration and angiogenesis in nasopharyngeal carcinoma
por: Gu, Miao, et al.
Publicado: (2017)

Tuning PFKFB3 Bisphosphatase Activity Through Allosteric Interference
por: Macut, Helena, et al.
Publicado: (2019)

PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs
por: Lypova, Nadiia, et al.
Publicado: (2021)

Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors
por: Alvarez, Reinier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0g0ko9b1mfim0tqv42o1nkd4rn